Nexalogy Enters into License and Development Agreement with Revive to Develop AI Component in Blockchain Enabled Patient-Focused Program Pharmaceutical Investing
Corbus Gets Patent Covering Use of Anabasum for the Treatment of Rare Fibrotic Diseases Pharmaceutical Investing
3D Signatures Inc. Announces Non-Brokered Private Placement to Raise $1,500,000 and Updates Previously Announced Brokered Private Placement Genetics Investing
DelMar Presents Positive Interim Results from VAL-083 Study in MGMT-unmethylated Recurrent GBM at The Society for NeuroOncology Annual Meeting Pharmaceutical Investing
Algae Dynamics Corp Annouces C$400,000 Research Grant From Mitacs To Support Cannabis Research Pharmaceutical Investing
